| Year |
Citation |
Score |
| 2024 |
Spisak S, Chen D, Likasitwatanakul P, Doan P, Li Z, Bala P, Vizkeleti L, Tisza V, De Silva P, Giannakis M, Wolpin B, Qi J, Sethi NS. Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system. Nature Communications. 15: 2230. PMID 38472198 DOI: 10.1038/s41467-024-46285-w |
0.416 |
|
| 2024 |
Singh H, Sahgal P, Kapner K, Corsello SM, Gupta H, Gujrathi R, Li YY, Cherniack AD, El Alam R, Kerfoot J, Andrews E, Lee A, Nambiar C, Hannigan AM, Remland J, ... ... Sethi NS, et al. RAS/RAF co-mutation and ERBB2 copy number modulates HER2 heterogeneity and responsiveness to HER2-directed therapy in colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38345769 DOI: 10.1158/1078-0432.CCR-23-2581 |
0.496 |
|
| 2024 |
Spisak S, Chen D, Likasitwatanakul P, Doan P, Li Z, Bala P, Vizkeleti L, Tisza V, De Silva P, Giannakis M, Wolpin B, Qi J, Sethi NS. Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer. Biorxiv : the Preprint Server For Biology. PMID 38293113 DOI: 10.1101/2023.06.21.545895 |
0.412 |
|
| 2023 |
Prosz A, Duan H, Tisza V, Sahgal P, Topka S, Klus GT, Börcsök J, Sztupinszki Z, Hanlon T, Diossy M, Vizkeleti L, Stormoen DR, Csabai I, Pappot H, Vijai J, ... ... Sethi N, et al. Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. Scientific Reports. 13: 20567. PMID 37996508 DOI: 10.1038/s41598-023-47946-4 |
0.775 |
|
| 2023 |
Sahgal P, Patil DT, Bala P, Sztupinszki ZM, Tisza V, Spisak S, Luong AG, Huffman B, Prosz A, Singh H, Lazaro JB, Szallasi Z, Cleary JM, Sethi NS. Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. Iscience. 26: 108169. PMID 37965133 DOI: 10.1016/j.isci.2023.108169 |
0.751 |
|
| 2023 |
Sahgal P, Patil DT, Sztupinszki ZM, Tisza V, Spisak S, Huffman B, Prosz A, Singh H, Lazaro JB, Szallasi Z, Cleary JM, Sethi NS. Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. Biorxiv : the Preprint Server For Biology. PMID 37034740 DOI: 10.1101/2023.03.27.534412 |
0.774 |
|
| 2023 |
Bala P, Rennhack JP, Aitymbayev D, Morris C, Moyer SM, Duronio GN, Doan P, Li Z, Liang X, Hornick JL, Yurgelun MB, Hahn WC, Sethi NS. Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Science Advances. 9: eadf0927. PMID 36989360 DOI: 10.1126/sciadv.adf0927 |
0.657 |
|
| 2023 |
Prosz A, Duan H, Tisza V, Sahgal P, Topka S, Klus GT, Börcsök J, Sztupinszki Z, Hanlon T, Diossy M, Vizkeleti L, Stormoen DR, Csabai I, Pappot H, Vijai J, ... ... Sethi N, et al. Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. Biorxiv : the Preprint Server For Biology. PMID 36798363 DOI: 10.1101/2023.02.07.527498 |
0.737 |
|
| 2023 |
Keller RB, Mazor T, Sholl L, Aguirre AJ, Singh H, Sethi N, Bass A, Nagaraja AK, Brais LK, Hill E, Hennessey C, Cusick M, Del Vecchio Fitz C, Zwiesler Z, Siegel E, et al. Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. Jco Precision Oncology. 7: e2200342. PMID 36634297 DOI: 10.1200/PO.22.00342 |
0.609 |
|
| 2023 |
Chatila WK, Walch H, Hechtman JF, Moyer SM, Sgambati V, Faleck DM, Srivastava A, Tang L, Benhamida J, Ismailgeci D, Campos C, Wu F, Chang Q, Vakiani E, de Stanchina E, ... ... Sethi NS, et al. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nature Communications. 14: 110. PMID 36611031 DOI: 10.1038/s41467-022-35592-9 |
0.654 |
|
| 2022 |
Peng K, Zhang F, Wang Y, Sahgal P, Li T, Zhou J, Liang X, Zhang Y, Sethi N, Liu T, Zhang H, Bass AJ. Development of combination strategies for Focal Adhesion Kinase inhibition in Diffuse Gastric Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36278961 DOI: 10.1158/1078-0432.CCR-22-1609 |
0.782 |
|
| 2022 |
Tanton H, Sewastianik T, Seo HS, Remillard D, Pierre RS, Bala P, Aitymbayev D, Dennis P, Adler K, Geffken E, Yeoh Z, Vangos N, Garbicz F, Scott D, Sethi N, et al. A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Science Advances. 8: eabm3108. PMID 35486727 DOI: 10.1126/sciadv.abm3108 |
0.672 |
|
| 2021 |
Kim M, Ly SH, Xie Y, Duronio GN, Ford-Roshon D, Hwang JH, Sulahian R, Rennhack JP, So J, Gjoerup O, Talamas JA, Grandclaudon M, Long HW, Doench JG, Sethi NS, et al. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis. Developmental Cell. PMID 34990589 DOI: 10.1016/j.devcel.2021.12.006 |
0.406 |
|
| 2021 |
Sahgal P, Huffman BM, Patil DT, Chatila WK, Yaeger R, Cleary JM, Sethi NS. Early Alterations Shape Gastric and Esophageal Cancer Development. Cancers. 13. PMID 34885025 DOI: 10.3390/cancers13235915 |
0.789 |
|
| 2021 |
Liang X, Duronio GN, Yang Y, Bala P, Hebbar P, Spisak S, Sahgal P, Singh H, Zhang Y, Xie Y, Cejas P, Long HW, Bass AJ, Sethi NS. An enhancer-driven stem cell-like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer. Gastroenterology. PMID 34571027 DOI: 10.1053/j.gastro.2021.09.044 |
0.747 |
|
| 2021 |
Cleary JM, Wolpin BM, Dougan SK, Raghavan S, Singh H, Huffman B, Sethi NS, Nowak JA, Shapiro GI, Aguirre AJ, D'Andrea AD. Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34285063 DOI: 10.1158/1078-0432.CCR-21-1367 |
0.322 |
|
| 2020 |
Sethi NS, Kikuchi O, Duronio GN, Stachler MD, McFarland JM, Ferrer-Luna R, Zhang Y, Bao C, Bronson R, Patil D, Sanchez-Vega F, Liu JB, Sicinska E, Lazaro JB, Ligon KL, et al. Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model. Nature Genetics. PMID 32025000 DOI: 10.1038/S41588-019-0574-9 |
0.639 |
|
| 2019 |
Sethi N, Kikuchi O, McFarland J, Zhang Y, Chung M, Kafker N, Islam M, Lampson B, Chakraborty A, Kaelin WG, Bass AJ. Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma. Jci Insight. 4. PMID 31391338 DOI: 10.1172/Jci.Insight.128439 |
0.629 |
|
| 2019 |
Keller RB, Mazor T, Giannakis M, Nowak J, Sholl L, Aguirre A, Bass A, Sethi N, Nagaraja A, Brais L, Reilly E, Cerami E, Wolpin B. Abstract C130: Precision oncology decision support within the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute (GI TARGET) Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-C130 |
0.326 |
|
| 2018 |
Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. PMID 29622466 DOI: 10.1016/J.Ccell.2018.03.010 |
0.579 |
|
| 2016 |
Hayakawa Y, Sethi N, Sepulveda AR, Bass AJ, Wang TC. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nature Reviews. Cancer. 16: 305-18. PMID 27112208 DOI: 10.1038/nrc.2016.24 |
0.638 |
|
| 2010 |
Gandhi G, Londoño D, Whetstine CR, Sethi N, Kim KS, Zückert WR, Cadavid D. Interaction of variable bacterial outer membrane lipoproteins with brain endothelium. Plos One. 5: e13257. PMID 21063459 DOI: 10.1371/journal.pone.0013257 |
0.535 |
|
| 2006 |
Sethi N, Sondey M, Bai Y, Kim KS, Cadavid D. Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infection and Immunity. 74: 6408-18. PMID 16940140 DOI: 10.1128/IAI.00538-06 |
0.569 |
|
| 2005 |
Wolansky LJ, Haghighi MH, Sevdalis E, Cook SD, Sethi N, Liu J, Joseph G, Tulloch K, Cadavid D. Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 15: 289-90. PMID 15951416 DOI: 10.1111/J.1552-6569.2005.Tb00326.X |
0.538 |
|
| Show low-probability matches. |